Stock YSG YATSEN HOLDING LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Yatsen Holding Limited

Equities

YSG

US9851942089

Market Closed - Nyse
Other stock markets
 01:30:02 27/04/2024 am IST 		5-day change 1st Jan Change
4.84 USD +8.28% Intraday chart for Yatsen Holding Limited +29.07% +32.31%
11/04 Yatsen Holding Regains Compliance With NYSE Minimum Share Price Requirement MT
15/03 ADRs End Lower; Akso Health Group Declines 23% DJ

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.
  • The company has a poor ESG score according to Refinitiv, which ranks companies by sector.

Strengths

  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The stock, which is currently worth 2023 to -0.43 times its sales, is clearly overvalued in comparison with peers.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company has a low valuation given the cash flows generated by its activity.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Personal Products

1st Jan change Capi. Investor Rating ESG Refinitiv
YATSEN HOLDING LIMITED Stock Yatsen Holding Limited
+32.31% 521M
D+
L'ORÉAL Stock L'Oréal
-3.33% 249B
B-
KAO CORPORATION Stock Kao Corporation
+10.09% 18.86B
B+
GALDERMA GROUP AG Stock Galderma Group AG
0.00% 17.37B - -
SHISEIDO COMPANY, LIMITED Stock Shiseido Company, Limited
-1.32% 10.65B
A-
COTY INC. Stock Coty Inc.
-7.73% 10.26B
A-
AMOREPACIFIC CORPORATION Stock Amorepacific Corporation
+3.86% 6.72B
B+
PROYA COSMETICS CO.,LTD. Stock Proya Cosmetics Co.,Ltd.
+9.76% 5.94B
B
NATURA &CO HOLDING S.A. Stock Natura &Co Holding S.A.
-0.06% 4.55B
B+
INTER PARFUMS, INC. Stock Inter Parfums, Inc.
-16.98% 3.83B
C-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. YSG Stock
  4. Ratings Yatsen Holding Limited